首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase
【24h】

Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase

机译:通过使用胸腺嘧啶-DNA糖基糖酶从福尔马林固定的石蜡包埋的组织中减少DNA中的Artifactual EGFR T790M突变

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: False-positive EGFR T790M mutations have been reported in formalin-fixed lung tumors, but the cause of the false positives has not been identified. The T790M mutation results from a C > T change at the cytosine of a CpG dinucleotide. The presence or absence of methylation at this cytosine has different consequences following deamination, resulting in a thymine or uracil, respectively, both of which however result in an artifactual change. Uracil-DNA glycosylase (UDG) can be used to eliminate DNA templates with uracil residues but is not active against artifactual thymines. We therefore investigated the use of thymine-DNA glycosylase (TDG) to reduce artifactual T790M mutations.
机译:背景:福尔马林固定肺肿瘤报告了假阳性EGFR T790M突变,但尚未确定误报的原因。 T790M突变由C> T在CpG二核苷酸的胞嘧啶的变化中产生。 这种胞嘧啶在该胞嘧啶的存在或不存在在脱核后具有不同的后果,分别导致胸腺嘧啶或尿嘧啶,这两者都导致造成造工变化。 URACIL-DNA糖基糖酶(UDG)可用于消除具有尿嘧啶残留物的DNA模板,但对抗人类胸腺量不活跃。 因此,我们研究了使用胸腺嘧啶-DNA糖基酶(TDG)以减少艺术T790M突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号